AdipoGen Life Sciences

PRT-060318

Product Code:
 
SYN-1204
Product Group:
 
Inhibitors and Activators
Regulatory Status:
 
RUO
Shipping:
 
-20°C
1 / 1
Chemical Structure

Chemical Structure

No additional charges, what you see is what you pay! *

CodeSizePrice
SYN-1204-M100100 mgEnquire
Quantity:
SYN-1204-M05050 mgEnquire
Quantity:
SYN-1204-M0011 mg£186.00
Quantity:
SYN-1204-M0055 mg£420.00
Quantity:
SYN-1204-M01010 mg£654.00
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: Switzerland.
Typical lead time: 7-10 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Alternate Names/Synonyms:
PRT060318
Appearance:
Solid.
CAS:
1194961-19-7
EClass:
32160000
Form (Short):
liquid
InChi:
InChI=1S/C18H24N6O/c1-11-5-4-6-12(9-11)22-17-13(16(20)25)10-21-18(24-17)23-15-8-3-2-7-14(15)19/h4-6,9-10,14-15H,2-3,7-8,19H2,1H3,(H2,20,25)(H2,21,22,23,24)/t14-,15+/m0/s1
InChiKey:
NZNTWOVDIXCHHS-LSDHHAIUSA-N
Long Description:
Chemical. CAS: 1194961-19-7. Formula: C18H24N6O. MW: 340.4. PRT-060318, a novel Syk inhibitor, prevents heparin-induced thrombocytopenia and thrombosis in a transgenic mouse model.
Molecular Formula:
C18H24N6O
Molecular Weight:
340.4
Package Type:
Plastic Vial
Product Description:
PRT-060318, a novel Syk inhibitor, prevents heparin-induced thrombocytopenia and thrombosis in a transgenic mouse model.
Purity:
>95%
Solubility Chemicals:
Soluble in DMSO.
Transportation:
Non-hazardous
UNSPSC Category:
Protein Kinase Modulators
UNSPSC Number:
12352200
Use & Stability:
Stable for at least 2 years after receipt when stored at -20°C.

References

Selective, novel spleen tyrosine kinase (Syk) inhibitors suppress chronic lymphocytic leukemia B-cell activation and migration: J. Hoellenriegel, et al.; Leukemia 26, 1576 (2012)